Infectious Disease
National Jewish Health was founded in 1899 as a hospital to treat patients with tuberculosis infections. Since our inception, we have made groundbreaking discoveries in infectious disease research. Our physician-scientists were among the leaders in developing combined chemotherapy treatments for fighting tuberculosis. Here is an overview of our infectious disease research programs:
- Non-Tuberculosis Mycobacterial (NTM) Lung Infection Research: Our research focuses on understanding and treating NTM infections in individuals with bronchiectasis. This research spans genetics, epidemiology, pathogenesis, diagnostics and treatment strategies.
- Clinical Trials and Studies: Our physician-scientists conduct clinical trials to evaluate new and emerging treatments for pulmonary infections, aiming to improve patient outcomes and develop more effective therapies.
- Infectious Disease Research Advancements: Developed the culture medium to grow tuberculosis. Combined chemotherapy for tuberculosis. Novel anti-viral lipid therapeutics against COVID and influenza virus.
-
Jamie Barr, PhD
-
Hong Wei Chu, MD
-
James L. Crooks, PhD, MS
-
Charles L. Daley, MD
-
Brian J. Day, PhD
-
Gregory P. Downey, MD, FRCPC
-
Katherine Hisert, MD, PhD
-
Patrick S. Hume, MD, PhD
-
Shannon H. Kasperbauer, MD
-
Camille M. Moore, PhD
-
Jerry A. Nick, MD
-
Mari Numata-Nakamura, MD, PhD
-
Cristina Penaranda, PhD
-
Lilliana Radoshevich, PhD
-
R. Lee Reinhardt, PhD
-
Jeff Swigris, DO, MS
-
Elizabeth Wynn, PhD
-
Soonho Yoon, MD, PhD
-
Gongyi Zhang, PhD